Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by Accountprinceon Sep 21, 2022 1:21pm
252 Views
Post# 34976848

RE:RE:RE:Which Trick Pony will get recognized first?

RE:RE:RE:Which Trick Pony will get recognized first?I think all the informed shareholders here have noted that this current funding process is unfolding much differently than in the past.  Given that funds will be necessary by mid-October we are now at the "last minute" for funding.  Seto had also verbally stated that he'd extend any equity issue offering to all shareholders.  If that word is kept any equity issue would take at least 30 days compared to the instant gratification of a private placement.  So I do believe we - at best - are at the last minute for any equity issue.

So I mirror your sentiments in wondering what will actually get done.  Debt?  Perhaps but nothing is all that different and how do you service debt if you have negative cashflow?  So then partial to full realization of our assets pops to mind.  One pony or the other or both?  A partial sale to a partner or the whole thing?  Any partial sale would have to be at lower than FMV as a minority discount.  And only a financial partner would have any interest in a minority position.  So if a strategic partner they would want to have the right to the whole thing or else why bother?

If Spectral was granting access to control in the future why wouldn't they just sell now?  Because under those circumstances there would be no competing offers by other parties on completion of FDA approvals as they would only help establish the price between the parties and gain nothing for themselves.

All that being said, I will order what I feel is the most remote possibility to the most likely possibility.  Most remote is an equity issue, then a debt issue, then a partial sale of one or the other or both with the most probable being a sale of one or the other or both.
<< Previous
Bullboard Posts
Next >>